Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray 2021-10-21 15:58
IND Application for Phase III Clinical Study of Anti-HER2 Bispecific Antibody KN026 was Officially Accepted by CDE 2021-10-21 10:31
Singapore-based Biosyngen receives 500 million yuan in investment 2021-10-21 09:30
GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research 2021-10-21 08:05
EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization 2021-10-20 22:34
BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine 2021-10-20 21:24
Creatus Biosciences Inc. acquires the exclusive option to IP Assets from Stora Enso to Commercialize Xylitol Bioproduction from Biomass 2021-10-20 21:00
HistoIndex and Galecto to Collaborate on Galecto's Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology 2021-10-20 18:00
Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China 2021-10-20 07:00
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program 2021-10-20 05:08
Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer 2021-10-19 23:30
Excelra Announces Addition of Sudip Nandy to its Board of Directors 2021-10-19 21:00
Moët Hennessy Breaks New Ground For Innovation: The Robert-Jean De Vogüé Research Center 2021-10-19 21:00
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody 2021-10-19 20:00
Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease 2021-10-19 17:52
FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick 2021-10-19 15:01
CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections 2021-10-19 09:00
Australian businesses invited to advance the future of healthcare technologies in the Medtronic APAC Innovation Challenge 2021-10-19 06:51
Farmmi Healthcare Subsidiary Receives BRC and HACCP Certifications 2021-10-18 20:00
I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China 2021-10-18 20:00
1 215 216 217 218 219 452